If you’ve been researching kratom alkaloids, you’ve probably come across the term 7-hydroxymitragynine — often shortened to 7-OH. It’s one of the most talked-about compounds in the botanical wellness space right now, and for good reason.
This guide covers everything: what 7-hydroxymitragynine actually is, how it differs from kratom, its legal status, how 7-OH tablets are made and sold, and what to look for when shopping. Whether you’re completely new or just trying to fill in the gaps, this is the article to bookmark.
What Is 7-Hydroxymitragynine?
7-hydroxymitragynine is a naturally occurring alkaloid found in the leaves of Mitragyna speciosa, the tropical plant commonly known as kratom. It’s one of dozens of alkaloids present in the plant, but it’s attracted particular scientific and commercial attention because of its unique pharmacological profile.
In raw kratom leaf, 7-OH exists in very small concentrations — typically less than 2% of total alkaloid content. Despite this, researchers have found it to be a highly potent compound relative to its concentration. [Kruegel, A.C. et al. (2019). 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects. ACS Central Science. 🔗 https://pubmed.ncbi.nlm.nih.gov/31263758/]
The compound is classified as an indole alkaloid, sharing structural characteristics with other plant-derived alkaloids but acting through its own distinct mechanisms in the body.
7-OH vs. Kratom: Key Differences
Many people assume 7-hydroxymitragynine and kratom are the same thing. They’re not.
Kratom refers to the whole plant — the leaf, powder, or extract made from Mitragyna speciosa. It contains a complex mixture of alkaloids, with mitragynine being the most abundant (typically 60–70% of alkaloid content). 7-OH is one of many minor alkaloids found alongside it.
7-OH products, on the other hand, are typically isolated or heavily concentrated extracts where 7-hydroxymitragynine is the primary active compound. This is a meaningful distinction:
- Kratom powder/leaf: broad alkaloid profile, lower individual alkaloid concentration
- 7-OH tablets: concentrated, standardized to deliver a specific amount of 7-hydroxymitragynine
The result is a significantly different experience and potency profile. Products marketed as “7-OH tablets” are not simply kratom in a different form — they’re a distinct category of botanical product. [Kruegel, A.C. et al. (2016). Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids. PMC / JACS. 🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC5189718/]
How 7-Hydroxymitragynine Works
7-hydroxymitragynine interacts primarily with opioid receptors in the body, particularly mu-opioid receptors (MOR). This is the same receptor class targeted by many conventional analgesic compounds, which explains why the research community has taken a serious interest in it. [Matsumoto, K. et al. (2004). Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sciences. 🔗 https://pubmed.ncbi.nlm.nih.gov/14969718/]
What makes 7-OH biochemically interesting is how it compares to other MOR-targeting compounds in terms of binding affinity relative to its naturally occurring concentrations. Some early research suggested unusually high potency per unit of concentration, though the full picture of its pharmacokinetics is still being studied. [University of Florida Department of Cellular and Systems Pharmacology — Kratom Resources (ongoing reference page). 🔗 https://csp.pharmacy.ufl.edu/research/kratom/]
It’s also worth noting that 7-OH may behave as a biased agonist — meaning it may preferentially activate certain downstream signaling pathways over others. This property is a major focus of ongoing pharmaceutical research, as biased agonism is associated with different side-effect profiles compared to traditional opioid compounds. [Kruegel, A.C. et al. (2016). Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. PMC. 🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC5189718/]
The science here is genuinely fascinating, even if much of it is still preliminary. 7-hydroxymitragynine sits at the intersection of natural product chemistry and receptor pharmacology in a way that few other botanical compounds do.
What Are 7-OH Tablets?
7-OH tablets are a commercial format for delivering a standardized amount of 7-hydroxymitragynine in a convenient, pre-measured form. Rather than loose powder or liquid extracts, tablets offer precise, consistent amounts per serving.
These products have grown significantly in the market over the past few years, driven by consumer preference for convenience and consistency. A tablet is easy to carry, easy to store, and takes the guesswork out of serving size in a way that raw powder doesn’t.
[https://7ohmarket.com]
What to Look For in a 7-OH Tablet
Not all 7-OH tablets are created equal. Here’s what matters when evaluating a product:
- Declared mg content: Reputable brands clearly state the amount of 7-hydroxymitragynine per tablet. Vague labels are a red flag.
- Third-party testing: Lab-tested products provide a certificate of analysis (COA) that verifies alkaloid content and checks for contaminants.
- Count per pack: Tablet counts typically range from 3 to 10 per pack. Higher counts usually offer better per-tablet value.
- Brand transparency: Look for brands that publish sourcing and testing information. Opacity in this space is a concern.
7-OH Brands on the Market
The 7-OH tablet market has expanded considerably, with a growing number of brands offering products across a wide mg spectrum. Here’s a look at some of the major players:
| Brand | mg Per Tablet | Count | Strength Level |
| Straight Heat 150s | 150mg | 4ct | Entry/Mid |
| Straight Heat 80s | 80mg | 3ct | Entry |
| 7Stax | 100mg | 5ct | Mid |
| Dozo Perks | 100mg | 4ct | Mid |
| Numbz | 50mg | 10ct | Entry/Mid |
| Zourz | 100mg | 5ct | Mid |
| 7Tabz | 65mg | 4ct | Mid |
| Smurph’s | 80mg | 5ct | Entry/Mid |
| Limitless Black | 50mg | 10ct | Entry/Mid |
| Opia | 80mg | 4ct | Entry |
| 7 Star | 30mg | 5ct | Entry |
| 7Hydroxymitragy9 | 25–80mg | 5–10ct | Low–Entry |
Note: mg figures represent 7-hydroxymitragynine content per tablet as declared by brand labeling. Always verify with the most current product listing.
The range here is significant — from 25mg entry-level options to 150mg+ high-concentration products. For anyone new to 7-OH tablets, starting at the lower end of the spectrum is the general approach.
https://7ohmarket.com/product/opia
Is 7-Hydroxymitragynine Legal?
This is one of the most common questions in the 7-OH space, and the honest answer is: it depends on where you are.
At the federal level in the United States, 7-hydroxymitragynine is not currently a controlled substance under the DEA’s schedules. However, several individual states have enacted their own regulations that restrict or ban kratom-derived alkaloids — including 7-OH — at the state level.
States where 7-OH products are currently restricted or unavailable for shipment:
Alabama, Arkansas, California, Florida, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Ohio, Tennessee, Rhode Island, Vermont, and Wisconsin.
This list is subject to change as state legislatures continue to address kratom and kratom-derived compounds. Always verify current regulations in your state before purchasing.
Outside of the U.S., regulations vary significantly by country. The European Union, the UK, Australia, and several Southeast Asian countries have their own frameworks — some permissive, some restrictive. Research your local laws before importing or purchasing.
The Kratom Consumer Protection Act (KCPA)
Several states have adopted — or are considering — the Kratom Consumer Protection Act (KCPA), a model legislation framework developed by the American Kratom Association. The KCPA aims to regulate the production and sale of kratom products (including 7-OH extracts) rather than banning them outright.
Under KCPA frameworks, products must typically meet labeling requirements, age restrictions (18 or 21+), and testing standards. This is generally seen as a consumer-positive development — it creates accountability in the market rather than prohibition. [https://www.americankratom.org/]
7-OH and Ongoing Research
The scientific literature on 7-hydroxymitragynine is still emerging, but it’s growing. Here are some areas of active research:
Pain management research: Because of its MOR activity, 7-OH has attracted attention from researchers exploring non-traditional analgesic compounds. Early studies have shown meaningful binding affinity, though clinical data in humans remains limited.
Addiction and dependency potential: Any compound that interacts with opioid receptors raises legitimate questions about dependency. Researchers are studying 7-OH’s dependency profile compared to traditional opioids, with some preliminary data suggesting a different risk profile — but this work is ongoing. [Hemby, S.E. et al. (2019). Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addiction Biology. PubMed. 🔗 https://pubmed.ncbi.nlm.nih.gov/29949228/]
Pharmaceutical interest: The pharmaceutical sector has taken note. Several research groups and biotech companies have explored kratom alkaloids as lead compounds for drug development, specifically because of the biased agonism properties mentioned earlier. [ PMC (2021). Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy. NIH/PMC. 🔗 https://pmc.ncbi.nlm.nih.gov/articles/PMC8219695/]
This doesn’t mean 7-OH tablets are pharmaceutical products — they aren’t, and no 7-OH tablet on the market makes drug claims. But the underlying compound is genuinely being studied at a serious scientific level, which is unusual for a botanical product.
How 7-OH Tablets Are Made
The production of 7-OH tablets starts with raw kratom leaf or kratom extract. From there, the process typically involves:
- Extraction: Isolating alkaloids from the plant material using solvent-based or CO₂ extraction methods
- Concentration: Reducing the extract to increase the relative proportion of 7-hydroxymitragynine
- Formulation: Combining the concentrated extract with binding agents and pressing into tablet form
- Testing: Third-party lab testing to verify potency and screen for contaminants (heavy metals, pesticides, microbials)
- Packaging: Labeling with declared mg content, count, and required compliance information
The quality of each step matters enormously. Differences in extraction method, starting material quality, and testing rigor explain much of the variation between brands in the market.
Buying 7-OH Tablets: What to Expect
When shopping for 7-OH tablets, here’s what the purchasing experience typically looks like:
Online retail is the primary channel. Most reputable brands sell through specialty online retailers rather than brick-and-mortar stores, though that’s beginning to change in certain markets.
Pricing generally ranges from around $18 to $68 per pack, depending on brand, mg content, and tablet count. Value-per-mg comparisons are useful when evaluating whether a higher-priced product is actually more economical.
Shipping is standard for most U.S. states not on the restricted list. Some retailers offer free shipping thresholds — 7OHMarket.com offers free priority shipping on orders over $150.
Age verification is standard practice among legitimate retailers. Most require buyers to be 18 or 21+, consistent with KCPA guidelines and general industry practice.
FAQ: 7-Hydroxymitragynine
What is 7-hydroxymitragynine?
7-hydroxymitragynine is a naturally occurring alkaloid found in the leaves of Mitragyna speciosa (kratom). It is present in small concentrations in the raw plant but is often isolated and concentrated for use in commercial 7-OH products, including tablets.
Is 7-hydroxymitragynine the same as kratom?
No. Kratom refers to the whole plant or unprocessed leaf/powder, which contains many alkaloids. 7-hydroxymitragynine is one specific alkaloid that can be isolated and concentrated from kratom. 7-OH tablets are a distinct product category.
Is 7-hydroxymitragynine legal in the United States?
At the federal level, 7-hydroxymitragynine is not a scheduled controlled substance. However, it is restricted or banned in a number of states. Always check your state’s current regulations before purchasing.
How are 7-OH tablets different from kratom powder?
Kratom powder is a minimally processed whole-plant product. 7-OH tablets are an extracted and concentrated form of a specific alkaloid, resulting in a significantly different potency and alkaloid profile.
What should I look for when buying 7-OH tablets?
Look for clearly declared mg content per tablet, third-party lab testing with available COAs, transparent brand information, and purchase from a reputable retailer that ships only to legal states.
Will 7-OH show up on a drug test?
Standard drug tests do not screen for kratom alkaloids. However, some specialized panels may detect mitragynine or its metabolites. This is a developing area and practices may vary. Consult relevant resources if this is a concern.
What mg of 7-OH tablet should a first-time buyer consider?
We don’t provide dosage recommendations. If you’re new to 7-OH products, research available options across the full mg range and make an informed decision. Lower-concentration products exist specifically for those new to the category.
Where to Buy 7-Hydroxymitragynine Tablets
If you’re in a state where 7-OH products are legal, 7OHMarket.com carries a curated selection of 7-hydroxymitragynine tablets from leading brands including 7Stax, Dozo Perks, Straight Heat, Numbz, Zourz, Limitless Black, Opia, and more.
All products are sourced from reputable manufacturers, and the site ships only to states where 7-OH products are legally permitted.
Shop 7-OH Tablets at 7OHMarket.com →
Free priority shipping on orders over $150. Products ship discreetly to all legal states.
Disclaimer: This product has not been evaluated by the Food and Drug Administration. These statements have not been evaluated by the FDA. This product has not been deemed fit for US consumption by the FDA. The information in this article is for educational purposes only and does not constitute medical advice. You accept full responsibility for the use of any product. Not recommended for long-term use or multiple uses consecutively. Not available for shipment to: Alabama, Arkansas, California, Florida, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Ohio, Tennessee, Rhode Island, Vermont, or Wisconsin.